Mama Check

Optimizing lateral Flow assay technology to improve accuracy and reliability for better prenatal health.

The Problem

Pre-eclampsia is a serious pregnancy complication characterized by high blood pressure and signs of damage to other organ systems, which contributes to up to 15% of maternal deaths globally. In Tanzania, pre-eclampsia is responsible for 40% of all maternal deaths, underscoring the urgent need for innovative healthcare solutions

Our Solution

The existing test for pre-eclampsia include blood pressure and proteinuria that is not specific enough, centralized laboratory tests for biomarkers are expensive and slow, rapid tests for glyFn are not validated in Europe. Ifakara Biotech brings you Mama Check, a rapid test that is easy to use, fast and reliable to detect specific biomarkers for preeclampsia.